Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GTHX

G1 Therapeutics (GTHX)

G1 Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GTHX
DateTimeSourceHeadlineSymbolCompany
09/28/20194:15AMGlobeNewswire Inc.G1 Therapeutics Presents Updated Data at ESMO 2019 from Randomized Phase 2 Trial of Trilaciclib in Combination with Chemother...NASDAQ:GTHXG1 Therapeutics Inc
09/13/20196:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GTHXG1 Therapeutics Inc
09/10/20196:01AMGlobeNewswire Inc.G1 Therapeutics to Present New Clinical Data Across Pipeline at European Society for Medical Oncology (ESMO) 2019 CongressNASDAQ:GTHXG1 Therapeutics Inc
09/03/20197:00AMGlobeNewswire Inc.G1 Therapeutics to Present at H.C. Wainwright Annual Global Investment Conference on September 9, 2019NASDAQ:GTHXG1 Therapeutics Inc
08/07/20195:18PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GTHXG1 Therapeutics Inc
08/07/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTHXG1 Therapeutics Inc
08/07/20194:01PMGlobeNewswire Inc.G1 Therapeutics Provides Second Quarter 2019 Corporate and Financial UpdateNASDAQ:GTHXG1 Therapeutics Inc
08/06/20197:00AMGlobeNewswire Inc.G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in AugustNASDAQ:GTHXG1 Therapeutics Inc
07/31/20197:00AMGlobeNewswire Inc.G1 Therapeutics to Provide Second Quarter Corporate and Financial Update on August 7, 2019NASDAQ:GTHXG1 Therapeutics Inc
07/30/20194:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
07/30/20194:29PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GTHXG1 Therapeutics Inc
07/30/20197:01AMGlobeNewswire Inc.G1 Therapeutics Appoints Mark Avagliano as Chief Business OfficerNASDAQ:GTHXG1 Therapeutics Inc
06/18/20196:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTHXG1 Therapeutics Inc
06/18/20196:00AMGlobeNewswire Inc.G1 Therapeutics Announces Updated Results from Phase 2 Trial of Trilaciclib in Combination with Chemotherapy Showed Statistic...NASDAQ:GTHXG1 Therapeutics Inc
06/14/20194:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/14/20194:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/14/20194:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/14/20194:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/14/20194:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/14/20194:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/14/20194:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/14/20197:01AMGlobeNewswire Inc.G1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Car...NASDAQ:GTHXG1 Therapeutics Inc
06/14/20196:13AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GTHXG1 Therapeutics Inc
06/13/20194:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTHXG1 Therapeutics Inc
06/13/20197:01AMGlobeNewswire Inc.G1 Therapeutics Announces Updates to Board of DirectorsNASDAQ:GTHXG1 Therapeutics Inc
06/11/20197:00AMGlobeNewswire Inc.G1 Therapeutics to Present at Raymond James Life Sciences and MedTech ConferenceNASDAQ:GTHXG1 Therapeutics Inc
06/01/20194:00PMGlobeNewswire Inc.G1 Therapeutics Presents Additional Phase 2 Data on Trilaciclib in Small Cell Lung Cancer at 2019 American Society of Clinica...NASDAQ:GTHXG1 Therapeutics Inc
05/29/20198:45AMInvestorWireBiotechs That Successfully Combat Cancer Could See Blockbuster ReturnsNASDAQ:GTHXG1 Therapeutics Inc
05/16/20197:00AMGlobeNewswire Inc.G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical On...NASDAQ:GTHXG1 Therapeutics Inc
05/13/20197:00AMGlobeNewswire Inc.G1 Therapeutics to Present at UBS Global Healthcare ConferenceNASDAQ:GTHXG1 Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GTHX